| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±2.8% | -5.2% | under-priced |
| 11/04/2025 | ±1.9% | +1.0% | over-priced |
| 08/07/2025 | ±3.0% | +0.4% | over-priced |
| 04/30/2025 | ±2.4% | +3.8% | under-priced |
| 10/30/2024 | ±1.9% | +3.6% | under-priced |
| 08/08/2024 | ±4.0% | +0.1% | over-priced |
| 04/30/2024 | ±2.2% | -2.6% | under-priced |
| 11/01/2023 | ±2.6% | +7.4% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $4.17 | $1.9B | $251M |
| Q1 FY2026 | $25.10 | $1.4B | $1.5B |
| Q4 FY2025 | $4.62 | $1.5B | $279M |
| Q3 FY2025 | $6.85 | $1.8B | $414M |
Martin Marietta Materials (MLM) reports in 115 days, with the next report estimated for 01/05/2027. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 3.0% on average — the market has been roughly fair on MLM's earnings risk. Fundamentals into the print: EPS down 23.2% year-over-year, revenue up 21.0%. QuantLogix's live 5-factor engine currently reads MLM as a neutral at 44/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →